JP2008189659A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008189659A5 JP2008189659A5 JP2008002754A JP2008002754A JP2008189659A5 JP 2008189659 A5 JP2008189659 A5 JP 2008189659A5 JP 2008002754 A JP2008002754 A JP 2008002754A JP 2008002754 A JP2008002754 A JP 2008002754A JP 2008189659 A5 JP2008189659 A5 JP 2008189659A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- aromatic heterocyclic
- hydrogen atom
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 27
- 239000003814 drug Substances 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 21
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000001072 heteroaryl group Chemical group 0.000 claims 21
- 125000003545 alkoxy group Chemical group 0.000 claims 20
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 20
- 125000004414 alkyl thio group Chemical group 0.000 claims 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims 18
- 125000003118 aryl group Chemical group 0.000 claims 13
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 12
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 12
- 125000001589 carboacyl group Chemical group 0.000 claims 12
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 11
- -1 amino, carboxyl Chemical group 0.000 claims 10
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 claims 10
- 125000004043 oxo group Chemical group O=* 0.000 claims 10
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000003342 alkenyl group Chemical group 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 125000005368 heteroarylthio group Chemical group 0.000 claims 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 125000005199 aryl carbonyloxy group Chemical group 0.000 claims 6
- 125000004104 aryloxy group Chemical group 0.000 claims 6
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims 5
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 5
- 125000000335 thiazolyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 208000002249 Diabetes Complications Diseases 0.000 claims 2
- 125000003302 alkenyloxy group Chemical group 0.000 claims 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010012655 Diabetic complications Diseases 0.000 claims 1
- 206010029333 Neurosis Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 208000015238 neurotic disease Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000005389 trialkylsiloxy group Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008002754A JP4328820B2 (ja) | 2007-01-10 | 2008-01-10 | 医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007002904 | 2007-01-10 | ||
| JP2008002754A JP4328820B2 (ja) | 2007-01-10 | 2008-01-10 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008189659A JP2008189659A (ja) | 2008-08-21 |
| JP2008189659A5 true JP2008189659A5 (enExample) | 2008-11-13 |
| JP4328820B2 JP4328820B2 (ja) | 2009-09-09 |
Family
ID=39750102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008002754A Expired - Fee Related JP4328820B2 (ja) | 2007-01-10 | 2008-01-10 | 医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4328820B2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2162445B1 (en) | 2007-06-05 | 2013-11-27 | Takeda Pharmaceutical Company Limited | Heterobicyclic compounds as kinase inhibitors |
| EP2181987B9 (en) | 2007-08-23 | 2014-09-03 | Takeda Pharmaceutical Company Limited | 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer |
| US8193363B2 (en) | 2008-08-29 | 2012-06-05 | Astrazeneca Ab | Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
| JO3101B1 (ar) | 2008-12-02 | 2017-09-20 | Takeda Pharmaceuticals Co | مشتقات بنزوثيازول كعوامل مضادة للسرطان |
| US8293729B2 (en) * | 2009-06-24 | 2012-10-23 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical composition and methods relating thereto |
| CN102712582A (zh) * | 2010-01-29 | 2012-10-03 | 田边三菱制药株式会社 | (e)-羟基亚氨基苯基乙酸衍生物的制备方法 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| BR112015005631A2 (pt) * | 2012-09-26 | 2017-07-04 | Kowa Co | composto, composição farmacêutica, agente de ativação de glucoquinase, agente hipoglicêmico, agente para prevenir e/ou tratar pelo menos uma doença, métodos para ativar glucoquinase, para diminuir o nível de glicose no sangue e para prevenir e/ou tratar pelo menos uma doença, e, uso de um composto |
-
2008
- 2008-01-10 JP JP2008002754A patent/JP4328820B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008189659A5 (enExample) | ||
| CA2613303A1 (en) | An oxime derivative for use as a glucokinase activator | |
| US9670193B2 (en) | Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease | |
| US20130224151A1 (en) | Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain | |
| JP2013500267A5 (enExample) | ||
| JP2009534386A5 (enExample) | ||
| US20120220457A1 (en) | IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME | |
| Huang et al. | Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles | |
| JP2008007519A5 (enExample) | ||
| JP2010530431A5 (enExample) | ||
| RU2012129168A (ru) | Производные оксазина | |
| NZ623838A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus | |
| JP2018509418A5 (enExample) | ||
| RU2009138600A (ru) | Амиды диазабициклоалканов, селективные в отношении ацетилхолинового подтипа никотиновых рецепторов | |
| US20240287098A1 (en) | Compositions and methods for treating cancer | |
| JP2014506582A5 (enExample) | ||
| JP2016534124A5 (enExample) | ||
| JP2014518853A5 (enExample) | ||
| JP2018513190A5 (enExample) | ||
| MY181731A (en) | Azole benzene derivative | |
| JP2014533735A (ja) | 外寄生生物を防除するためのアリール誘導体の使用 | |
| CN103102348B (zh) | 噁二唑类化合物及其制备方法、药物组合物及其用途 | |
| AU2006236812A1 (en) | Combinations, methods and compositions for treating cancer | |
| US20140163013A1 (en) | Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome | |
| JP2008500378A5 (enExample) |